Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01924871Phase 4Completed
Phase 4, randomised trial of remifentanil, sponsored by Chung-Ang University Hospital. Primary endpoint: Awakening Time at 1 day. Started Jul 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01924871.